Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Accelerating a paradigm shift: The Common Fund Single Cell Analysis Program.

Roy AL, Conroy R, Smith J, Yao Y, Beckel-Mitchener AC, Anderson JM, Wilder EL.

Sci Adv. 2018 Aug 1;4(8):eaat8573. doi: 10.1126/sciadv.aat8573. eCollection 2018 Aug. Review.

2.

The State of the NIH BRAIN Initiative.

Koroshetz W, Gordon J, Adams A, Beckel-Mitchener A, Churchill J, Farber G, Freund M, Gnadt J, Hsu NS, Langhals N, Lisanby S, Liu G, Peng GCY, Ramos K, Steinmetz M, Talley E, White S.

J Neurosci. 2018 Jul 18;38(29):6427-6438. doi: 10.1523/JNEUROSCI.3174-17.2018. Epub 2018 Jun 19.

PMID:
29921715
3.

The PsychENCODE project.

PsychENCODE Consortium, Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, Weissman S, Sullivan PF, State MW, Weng Z, Peters MA, White KP, Gerstein MB, Amiri A, Armoskus C, Ashley-Koch AE, Bae T, Beckel-Mitchener A, Berman BP, Coetzee GA, Coppola G, Francoeur N, Fromer M, Gao R, Grennan K, Herstein J, Kavanagh DH, Ivanov NA, Jiang Y, Kitchen RR, Kozlenkov A, Kundakovic M, Li M, Li Z, Liu S, Mangravite LM, Mattei E, Markenscoff-Papadimitriou E, Navarro FC, North N, Omberg L, Panchision D, Parikshak N, Poschmann J, Price AJ, Purcaro M, Reddy TE, Roussos P, Schreiner S, Scuderi S, Sebra R, Shibata M, Shieh AW, Skarica M, Sun W, Swarup V, Thomas A, Tsuji J, van Bakel H, Wang D, Wang Y, Wang K, Werling DM, Willsey AJ, Witt H, Won H, Wong CC, Wray GA, Wu EY, Xu X, Yao L, Senthil G, Lehner T, Sklar P, Sestan N.

Nat Neurosci. 2015 Dec;18(12):1707-12. doi: 10.1038/nn.4156. Review. No abstract available.

4.

Neuroepigenomics: Resources, Obstacles, and Opportunities.

Satterlee JS, Beckel-Mitchener A, Little R, Procaccini D, Rutter JL, Lossie AC.

Neuroepigenetics. 2015 Jan 1;1:2-13.

5.

Community resources and technologies developed through the NIH Roadmap Epigenomics Program.

Satterlee JS, Beckel-Mitchener A, McAllister K, Procaccini DC, Rutter JL, Tyson FL, Chadwick LH.

Methods Mol Biol. 2015;1238:27-49. doi: 10.1007/978-1-4939-1804-1_2. Review.

PMID:
25421653
6.

Outcome measures for clinical trials in fragile X syndrome.

Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK; Outcome Measures Working Groups.

J Dev Behav Pediatr. 2013 Sep;34(7):508-22. doi: 10.1097/DBP.0b013e31829d1f20.

7.

Epigenetics in the nervous system.

Jiang Y, Langley B, Lubin FD, Renthal W, Wood MA, Yasui DH, Kumar A, Nestler EJ, Akbarian S, Beckel-Mitchener AC.

J Neurosci. 2008 Nov 12;28(46):11753-9. doi: 10.1523/JNEUROSCI.3797-08.2008. Review.

8.

Corticosterone response to acute stress in a mouse model of Fragile X syndrome.

Markham JA, Beckel-Mitchener AC, Estrada CM, Greenough WT.

Psychoneuroendocrinology. 2006 Jul;31(6):781-5. Epub 2006 Apr 18.

PMID:
16621323
9.

Autism and abnormal development of brain connectivity.

Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ.

J Neurosci. 2004 Oct 20;24(42):9228-31. Review. No abstract available.

10.

Autism as a disorder of neural information processing: directions for research and targets for therapy.

Belmonte MK, Cook EH Jr, Anderson GM, Rubenstein JL, Greenough WT, Beckel-Mitchener A, Courchesne E, Boulanger LM, Powell SB, Levitt PR, Perry EK, Jiang YH, DeLorey TM, Tierney E.

Mol Psychiatry. 2004 Jul;9(7):646-63. Review.

PMID:
15037868
11.

Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome.

Beckel-Mitchener A, Greenough WT.

Ment Retard Dev Disabil Res Rev. 2004;10(1):53-9. Review.

PMID:
14994289
12.

RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L, Carbonetto S, Weiler IJ, Greenough WT, Eberwine J.

Neuron. 2003 Feb 6;37(3):417-31.

13.

Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.

Churchill JD, Beckel-Mitchener A, Weiler IJ, Greenough WT.

Microsc Res Tech. 2002 May 1;57(3):156-8.

PMID:
12112451
14.

Poly(A) tail length-dependent stabilization of GAP-43 mRNA by the RNA-binding protein HuD.

Beckel-Mitchener AC, Miera A, Keller R, Perrone-Bizzozero NI.

J Biol Chem. 2002 Aug 2;277(31):27996-8002. Epub 2002 May 28.

15.

The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells.

Mobarak CD, Anderson KD, Morin M, Beckel-Mitchener A, Rogers SL, Furneaux H, King P, Perrone-Bizzozero NI.

Mol Biol Cell. 2000 Sep;11(9):3191-203.

16.

Overexpression of HuD, but not of its truncated form HuD I+II, promotes GAP-43 gene expression and neurite outgrowth in PC12 cells in the absence of nerve growth factor.

Anderson KD, Morin MA, Beckel-Mitchener A, Mobarak CD, Neve RL, Furneaux HM, Burry R, Perrone-Bizzozero NI.

J Neurochem. 2000 Sep;75(3):1103-14.

17.

Supplemental Content

Loading ...
Support Center